Cellectis (CLLS) Interest & Investment Income (2022 - 2026)
Cellectis' Interest & Investment Income came in at $4.74 million for Q2 2026, down 14.5% from $5.55 million a year earlier and down 60.2% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Interest & Investment Income (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cellectis reported Interest & Investment Income of $22.11 million, down 25.3% year-over-year; for FY2025, it came in at $16.12 million, down 63.7% from FY2024.
- Interest & Investment Income carries a five-year compound annual growth rate of 63.2% (FY2020 to FY2025).
- Going back by year, Interest & Investment Income was $44.41 million in FY2024 (+106.7%), $21.48 million in FY2023 (+141.9%), $8.88 million in FY2022 (-32.8%) and $13.22 million in FY2021 (+849.6%).
- The five-year range for quarterly Interest & Investment Income is -$6.28 million (Q4 2022) to $29.41 million (Q1 2024).
- Year-over-year, Interest & Investment Income increased in three of the last eight quarters, with growth averaging 3.2%.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q4 2024 (growth of 174.6%), and the weakest in Q4 2025 (a decline of 86.3%).
- Business Quant data shows CLLS's Interest & Investment Income at $11.89 million (Q1 2026), $2.02 million (Q4 2025) and $3.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Cellectis | 143.49 Mn | -609.91 Mn | - | 4.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.74 Mn |
| Mar 31, 2026 | 11.89 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 3.46 Mn |
| Jun 30, 2025 | 5.55 Mn |
| Mar 31, 2025 | 6.30 Mn |
| Dec 31, 2024 | 14.68 Mn |
| Sep 30, 2024 | 3.06 Mn |
| Jun 30, 2024 | 8.40 Mn |
| Mar 31, 2024 | 29.41 Mn |
| Dec 31, 2023 | 5.35 Mn |
| Sep 30, 2023 | 4.92 Mn |
| Jun 30, 2023 | 10.44 Mn |
| Mar 31, 2023 | 775,000.00 |
| Dec 31, 2022 | -6.28 Mn |
| Sep 30, 2022 | 2.90 Mn |
| Jun 30, 2022 | 9.99 Mn |
| Mar 31, 2022 | 2.27 Mn |
API Access
Cellectis Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();